Aehr Test Systems is navigating a volatile demand environment, with revenue surging 40.2% year-over-year to $19.8M in 2026Q4, yet operating income remains negative at -$993K, indicating that cost structure has not scaled with growth. The company's balance shee...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 14, 2026 | $0.11+1200.0% vs -$0.01 | $19M+0.6% vs $19M |
Q2 2026 Apr 7, 2026 | -$0.05+28.6% vs -$0.07 | $10M-5.0% vs $11M |
Q1 2026 Jan 8, 2026 | -$0.04+50.0% vs -$0.08 | $10M-14.5% vs $12M |
Q4 2025 Oct 6, 2025 | $0.01+0.0% vs $0.01 | $11M-1.3% vs $11M |
Tidal Investments LLC bought a new stake in Aehr Test Systems (NASDAQ: AEHR) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 15,737 shares of the semiconductor company's stock, valued at approximately $1,512,000. A number of other hedge funds and other institutional investors
Aehr broadens beyond SiC as AI, silicon photonics and power semiconductors fuel a more diversified growth story.
Some of the best AI stocks have been dumped in recent weeks. That trend should change soon.
On September 09, 2026, Aehr Test Systems (AEHR) shares rose 5.3% to $95.56, marking a notable rebound in the context of a 52-week range of $18.70 to $147.40. Th
Benchmark AEHR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Aehr Test Systems (AEHR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $97.38 | $3.06B | -423.39 | -15.21% | -14.25% | -4.16% | — | |
| $64.48 | $3.04B | -40.55 | 12.74% | -7.43% | -4.91% | — | |
| $118.43 | $3.64B | 31.17 | -17.57% | 10.71% | 8.91% | — | |
| $282.31 | $14.04B | 101.55 | 1.82% | 11.84% | 6.5% | — | |
| $58.40 | $2.04B | -37.92 | 11.61% | -3.97% | -5.61% | — | |
| $131.26 | $10.23B | 190.23 | 2.8% | 12.8% | 10.96% | — |
Aehr Test Systems (AEHR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Aehr Test Systems (AEHR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 14, 2026·SEC
Apr 20, 2026·SEC
Apr 8, 2026·SEC
Jul 28, 2025·SEC
Get notified when AEHR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Aehr Test Systems (AEHR) stock FAQ — growth, dividends, profitability & financials explained
Aehr Test Systems (AEHR) reported $50.9M in revenue for fiscal year 2026. This represents a 21% increase from $42.0M in 1997.
Aehr Test Systems (AEHR) saw revenue decline by 15.2% over the past year.
Aehr Test Systems (AEHR) reported a net loss of $7.1M for fiscal year 2026.
Aehr Test Systems (AEHR) has a return on equity (ROE) of -4.2%. Negative ROE indicates the company is unprofitable.
Aehr Test Systems (AEHR) had negative free cash flow of $5.4M in fiscal year 2026, likely due to heavy capital investments.
